Inventor · disambiguated record
Dinesh Barawkar
Also filed as: BARAWKAR DINESH
16 granted patents·4 pending applications·139 citations·filing 2003–2022
92Inventor score
Files withARDEA BIOSCIENCES INC3BARAWKAR DINESH3ARDEA BIOSCIENCES2IMPETIS BIOSCIENCES LTD2MADERNA ANDREAS2
Top patents by PatentIndex Score
20 records- 0194US7759518B2Derivatives of N-(arylamino) sulfonamides as inhibitors of MEKARDEA BIOSCIENCES·Filed 2008·Granted Jul 20, 2010·41 cites·4 claims
- 0292US8101799B2Derivatives of N-(arylamino) sulfonamides as inhibitors of MEKMADERNA ANDREAS·Filed 2007·Granted Jan 24, 2012·28 cites·77 claims
- 0389US8859566B2Substituted fused pyrimidine compoundsPALLE VENKATA·Filed 2010·Granted Oct 14, 2014·26 cites·13 claims
- 0487US7429667B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2006·Granted Sep 30, 2008·7 cites·13 claims
- 0583US7652047B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Granted Jan 26, 2010·4 cites·27 claims
- 0682US9115133B2Substituted fused tricyclic compounds, compositions and medicinal applications thereofBARAWKAR DINESH·Filed 2012·Granted Aug 25, 2015·16 cites·5 claims
- 0778US9593115B2Substituted fused tricyclic compounds, compositions, and medicinal applications thereofADVINUS THERAPEUTICS LTD·Filed 2013·Granted Mar 14, 2017·7 cites·6 claims
- 0872US8252797B2Heterocyclic compounds as adenosine receptor antagonistPALLE VENKATA·Filed 2009·Granted Aug 28, 2012·2 cites·12 claims
- 0969US8940751B2Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applicationsBARAWKAR DINESH·Filed 2011·Granted Jan 27, 2015·2 cites·5 claims
- 1069US8829052B2Derivatives of N-(arylamino)sulfonamides as inhibitors of MEKMADERNA ANDREAS·Filed 2011·Granted Sep 9, 2014·1 cites·23 claims
- 1167US11407758B2Tricyclic compounds, compositions and medicinal applications thereofIMPETIS BIOSCIENCES LTD·Filed 2019·Granted Aug 9, 2022·1 cites·12 claims
- 1267US8796290B2Substituted fused pyrimidine compounds, its preparation and uses thereofRAMDAS VIDYA·Filed 2010·Granted Aug 5, 2014·3 cites·16 claims
- 1363US11981679B2Tricyclic compounds, compositions and medicinal applications thereofIMPETIS BIOSCIENCES LTD·Filed 2022·Granted May 14, 2024·0 cites·12 claims
- 1463US9284316B2Substituted fused pyrimidine compoundsADVINUS THERAPEUTICS PRIVATE LTD·Filed 2014·Granted Mar 15, 2016·1 cites·13 claims
- 1559US2014378466A1Derivatives of n-(arylamino) sulfonamides as inhibitors of mekARDEA BIOSCIENCES·Filed 2014·Application pending·0 cites
- 1657US2020339577A11-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as ep4 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1754US2017183333A1Derivatives of n-(arylamino) sulfonamides as inhibitors of mekARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1846US2006074035A1Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infectionsHONG ZHI·Filed 2003·Application pending·0 cites
- 1944US10745397B21-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Aug 18, 2020·0 cites·5 claims
- 2032US9006177B2Fused tricyclic compounds as adenosine receptor antagonistBARAWKAR DINESH·Filed 2011·Granted Apr 14, 2015·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Dinesh Barawkar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →